Changes in Length of Stay for Neurological Geriatric Diseases in Korea between 2003 and 2007
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background and Purpose The elderly population and the prevalence of stroke, dementia, and Parkinson’s disease are increasing rapidly in Korea. The aim of this study was to establish the length of stay (LOS) for neurological geriatric diseases, and analyze this parameteraccording to healthcare institutions. Methods We used data from the Health Insurance Review and Assessment Service from 2003to 2007. Nineteen neurological geriatric diseases were classified into four groups: dementia, cerebral hemorrhage, cerebral infarction, and Parkinson’s disease. LOS was analyzed according to gender, age, insurance type, disease group, and type of healthcare institution. Results The LOS for neurological geriatric diseases lengthened from 5,550,193 days (10.8% of the total National Health Insurance admission days) in 2003 to 14,749,671 days (19.7%) in 2007. The mean LOS was 40.8 days in 2003, and lengthened to 71.2 days in 2007. After stratification by disease group, the mean LOS for long-term-care hospitals lengthened by 1.43 times (from 81.7 to 116.6 days) in the cerebral infarction group, 1.35 times (from 85.6 to 115.2 days) in the cerebral hemorrhage group, and 1.28 times (from 82.7 to 105.7 days) in the Parkinson’s disease group. Conclusions The LOS for neurological geriatric diseases has lengthened markedly, which isdue to an increasesin the number of hospitalized patients and the mean LOS, which have increased most rapidly in long-term-care hospitals. These results may be useful in developing geriatric health policies.
Abstract
Background and Purpose The elderly population and the prevalence of stroke, dementia, and Parkinson’s disease are increasing rapidly in Korea. The aim of this study was to establish the length of stay (LOS) for neurological geriatric diseases, and analyze this parameteraccording to healthcare institutions. Methods We used data from the Health Insurance Review and Assessment Service from 2003to 2007. Nineteen neurological geriatric diseases were classified into four groups: dementia, cerebral hemorrhage, cerebral infarction, and Parkinson’s disease. LOS was analyzed according to gender, age, insurance type, disease group, and type of healthcare institution. Results The LOS for neurological geriatric diseases lengthened from 5,550,193 days (10.8% of the total National Health Insurance admission days) in 2003 to 14,749,671 days (19.7%) in 2007. The mean LOS was 40.8 days in 2003, and lengthened to 71.2 days in 2007. After stratification by disease group, the mean LOS for long-term-care hospitals lengthened by 1.43 times (from 81.7 to 116.6 days) in the cerebral infarction group, 1.35 times (from 85.6 to 115.2 days) in the cerebral hemorrhage group, and 1.28 times (from 82.7 to 105.7 days) in the Parkinson’s disease group. Conclusions The LOS for neurological geriatric diseases has lengthened markedly, which isdue to an increasesin the number of hospitalized patients and the mean LOS, which have increased most rapidly in long-term-care hospitals. These results may be useful in developing geriatric health policies.
참고문헌 (25)
- Korea National Statistical Office, "Population Projections for Korea", pp.1~56 (2006), Korean National Statistical Office
- 나정호, "뇌졸중의 역학 2007 최신지견", 대한뇌졸중학회지, 10(1), pp.1~4 (2008), 대한뇌졸중학회
- Jeong HK, "Nationwide survey on the prevalence of Parkinson’s disease in Korea", Rep Natl Ins Health, 44, pp.442~445 (2007)
- Seoul National University Hospital, "Nationwide study on the Prevalence of Dementia in Korean Elders", pp.122~138 (2009), Division of Senior Policy, Ministry for Health, Welfare and Family Affairs (MIHWAF)
- "Enforcement Ordinance of the Long-Term Care Insurance Law for the Elderly"[URL]
- National Health Insurance Corporation, "Trend of treatment for geriatric diseases from 2002 to 2008" (2009), National Health Insurance Corporation (NHIC)
- Yu SH, "The determinants of length of stay in a university hospital", Yonsei Med J, 24, pp.38~45 (1983)
- Lee HJ, "An analysis on the effectiveness of hospital revenues per bed by shortening length of stay", Korean J Hosp Manage, 3, pp.100~120 (1998)
- 서동우, "사회인구학 및 임상적 특성과 입원시설 종류에 따른 정신보건시설 입원환자의 재원기간 분포", 신경정신의학, 41(6), pp.1174~1184 (2002), 대한신경정신의학회
- Lee YM, "Length of stay in the mental health facilities in Korea", J Korean Neuropsychiatr Assoc, 37, pp.83~94 (1998)
- 김선자, "서울소재 3차 의료기관에 재원 중인 노인 환자의 재원기간에 영향을 미치는 관련 요인", 병원경영학회지, 12(2), pp.25~42 (2007), 한국병원경영학회
- 이혜재, "일반층과 저소득층의 의료이용에 영향을 미치는 요인", 보건경제와 정책연구, 15(1), pp.79~106 (2009), 한국보건경제정책학회
- Kim SB, "Utilization rate of medical facility and its related factors in Taegu", Korean J Prev Med, 22, pp.29~44 (1989)
- National Health Insurance Corporation, "National Health Insurance Statistical Yearbook", pp.2008~ (2008), National Health Insurance Corporation, Health Insurance Review & Assessment Service
- Kang HK, "A study on hospital life of long term admitted patients in orthopedic surgery", 석사, pp.1982
- 허재혁, "건강보험심사평가원 자료를 이용한 5년간(2003-2007년) 치매 환자치료 추세동향", Dementia and Neurocognitive Disorders(대한치매학회지), 9(1), pp.29~35 (2010), 대한치매학회
- Korean Neurological Association, "Role and future of neurology in geriatric medicine", pp.9~26 (2009), Korean Neurological Association
- 박인수, "노인장기요양보험제도와 요양병원에 대하여", 노인병, 12(2), pp.68~73 (2008), 대한노인병학회[DOI]
- 김도훈, "한국형 노인요양병원 질 평가 도구 개발에 관한 고찰", 노인병, 12(4), pp.191~200 (2008), 대한노인병학회
- National Health Insurance Corporation, "National Health Insurance Statistical Yearbook" (2009), National Health Insurance Corporation, Health Insurance Review & Assessment Service
- 손민균, "재활의학과 입원 환자의 퇴원 양상", Annals of Rehabilitation Medicine, 27(2), pp.269~274 (2003), 대한재활의학회
- 박인수, "노인장기요양보험제도와 요양병원에 대하여", 노인병, 12(2), pp.68~73 (2008), 대한노인병학회[DOI]
- King B, "Relationship between dementia and length of stay of general medical patients admitted to acute care", Australas J Ageing, 25, pp.20~23 (2006)
- Chang KC, "Prediction of length of stay of first-ever ischemic stroke", Stroke, 33, pp.2670~2674 (2002)
- O’Brien JA, "Economic burden associated with Parkinson disease", Drug Benefit Trends, 21, pp.179~190 (2009)